 2. Patients that must take oral or injectable anticholinesterase inhibitors alone or in combination for the treatment of myasthenia gravis or as a reversal agent or antagonist to nondepolarizing muscle relaxants such as curariform drugs. Patients using eye medications for glaucoma are not excluded from the study. 